Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis

Metastasis accounts for approximately 90% of breast cancer-related deaths. Therefore, novel approaches which prevent or control breast cancer metastases are of significant clinical interest. Interleukin-12 (IL-12)-based immunotherapies have shown promise in controlling metastatic disease, yet modest...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncoimmunology
Prif Awduron: Vo, Jimmy LN, Yang, Lirong, Kurtz, Samantha L, Smith, Sean G, Koppolu, Bhanu prasanth, Ravindranathan, Sruthi, Zaharoff, David A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2015
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352958/
https://ncbi.nlm.nih.gov/pubmed/25964864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.968001
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg